A membrane glucocorticoid receptor mediates the rapid/non-genomic actions of glucocorticoids in mammalian skeletal muscle fibres

Journal of Physiology

Volumn 591, Issue 20, 2013, Pages 5171-5185

  Pérez, María Hernández Alcalá ^a   Cormack, Jonathan ^a   Mallinson, David ^b   Mutungi, Gabriel ^c  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; DACTINOMYCIN; GLUCOCORTICOID RECEPTOR; LAMININ; MIFEPRISTONE; PREDNISOLONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FAST MUSCLE FIBER; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; MAMMAL; MOUSE; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; SKELETAL MUSCLE; SLOW MUSCLE FIBER; WESTERN BLOTTING;

ANIMALS; BECLOMETHASONE; CELL MEMBRANE; CYTOPLASM; GLUCOCORTICOIDS; ISOMETRIC CONTRACTION; MICE; MUSCLE FIBERS, SLOW-TWITCH; ORGAN SPECIFICITY; PREDNISOLONE; PROTEIN TRANSPORT; RECEPTORS, GLUCOCORTICOID;

EID: 84885415431     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.256586     Document Type: Article

References (46)

1. Angelini C (2007). The role of corticosteroids in muscular dystrophy: A critical appraisal. Muscle Nerve 36, 424-435.
2. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D & Kupfer Y (2004). Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329, 480-484.
3. Barnes PJ (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94, 557-572.
4. Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D, Bienert M, Radbruch A, Burmester GR, Lauster R, Scheffold A & Buttgereit F (2004). Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J 18, 70-80.
5. Beutler B & Cerami A (1986). Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320, 584-588.
6. Bowyer SL, Lamothe MP & Hollister JR (1985). Steroid myopathy - incidence and detection in a population with asthma. J Allergy Clin Immunol 76, 234-242.
7. Buttgereit F, da Silva JAP, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Kohler L, van Riel P, Vischer T & Bijlsma JWJ (2002). Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61, 718-722.
8. Buttgereit F, Grant A, Muller M & Brand MD (1994). The effects of methylprednisolone on oxidative-phosphorylation in concanavalin-a-stimulated thymocytes - Top-down elasticity analysis and control analysis. Eur J Biochem 223, 513-519.
9. + ions into concanavalin A-stimulated thymocytes. Biochem J 326, 329-332.
10. Buttgereit F & Scheffold A (2002). Rapid glucocorticoid effects on immune cells. Steroids 67, 529-534.
11. Buttgereit F, Wehling M & Burmester GR (1998). A new hypothesis of modular glucocorticoid actions - Steroid treatment of rheumatic diseases revisited. Arthritis Rheum 41, 761-767.
12. Crossland H, Constantin-Teodosiu D, Greenhaff PL & Gardiner SM (2010). Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. J Physiol 588, 1333-1347.
13. Croxtall JD, Choudhary Q & Flower RJ (2000). Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130, 289-298.
14. Croxtal JD, van Hal PTW, Choudhury Q, Gilroy DW & Flower RJ (2002). Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br J Pharmacol 135, 511-519.
15. Dekhuijzen PNR, GayanRamirez G, deBock V, Dom R & Decramer M (1993). Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest 92, 1534-1542.
16. Dittmar KD, Demady DR, Stancato LF, Krishna P & Pratt WB (1997). Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery - The role of p23 is to stabilize receptor-hsp90 heterocomplexes formed by hsp90-p60-hsp70. J Biol Chem 272, 21213-21220.
17. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
18. Flück M, Carson JA, Gordon SE, Ziemiecki & Booth FW (1999). Focal adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle. Am J Physiol Cell Physiol 56, C152-C162.
19. Gametchu B (1987). Glucocorticoid receptor like antigen in lymphoma cell-membranes - Correlation to cell-lysis. Science 236, 456-461.
20. Gametchu B, Watson CS & Wu SH (1993). Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J 7, 1283-1292.
21. Hamdi M & Mutungi G (2010). Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres. J Physiol 588, 511-525.
22. Hamdi M & Mutungi G (2011). Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J Physiol 589, 3623-3640.
23. Hua SY & Chen YZ (1989). Membrane receptor-mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology 124, 687-691.
24. Koukouritaki SB, Margioris AN, Gravanis A, Hartig R & Stournaras C (1997). Dexamethasone induces rapid actin assembly in human endometrial cells without affecting its synthesis. J Cell Biochem 65, 492-500.
25. Kreamer WJ & Ratamess NA (2005). Hormonal responses and adaptations to resistance exercise and training. Sports Med 35, 339-361.
26. Lecker SH, Solomon V, Mitch WE & Goldberg AL (1999). Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129, 227S-237S.
27. Liberman AC, Castro CN, Antunica Noguerol M, Barcala Tabarrozzi AE, Druker J, Perone MJ & Arzt E (2010). Molecular mechanisms of glucocorticoids action: From basic research to clinical implications. Curr Immunol Rev 6, 371-380.
28. Lipworth BJ (2000). Therapeutic implications of non-genomic glucocorticoid activity. Lancet 356, 87-89.
29. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J & Salehian B (2003). Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285, E363-E371.
30. 2-adrenoceptor-independent mechanism. J App Physiol 109, 1716-1727.
31. Mayer U (2003). Integrins: Redundant or important players in skeletal muscle J Biol Chem 278, 14587-14590.
32. Merlini L, Gennari M, Malaspina E, Cecconi I, Armaroli A, Gnudi S, Talim B, Ferlini A, Cicognani A & Franzoni E (2012). Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up. Muscle Nerve 45, 796-802.
33. Michele DE & Campbell KP (2003). Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J Biol Chem 278, 15457-15460.
34. Moore BJ, Miller MJ, Feldman HA & Reid MB (1989). Diaphragm atrophy and weakness in cortisone-treated rats. J Appl Physiol 67, 2420-2426.
35. Mutungi G (2008). The expression of NFATc1 in adult rat skeletal muscle fibres. Exp Physiol 93, 399-406.
36. Nava S, GayanRamirez G, Rollier H, Bisschop A, Dom R, deBock V & Decramer M (1996). Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med 153, 1888-1896.
37. Orchinik M, Murray TF & Moore FL (1991). A corticosteroid receptor in neuronal membranes. Science 252, 1848-1851.
38. Pasquini F, Guerin C, Blake D, Davies K, Karpati G & Holland P (1995). The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal-muscle satellite cells. Neuromuscular Disorders 5, 105-114.
39. Sadoshima J & Izumo S (1997). The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59, 551-571.
40. Sanden S, Tripmacher R, Weltrich R, Rohde W, Hiepe F, Burmester GR & Buttgereit F (2000). Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 27, 1265-1270.
41. Sanes JR (2003). The basement membrane/basal lamina of skeletal muscle. J Biol Chem 278, 12601-12604.
42. Stahn C & Buttgereit F (2008). Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 4, 525-533.
43. Stahn C, Löwenberg M, Hommes DW & Buttgereit F (2007). Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275, 71-78.
44. van Balkom R, Folgering H, Fransen J & Dekhuijzen C (1997). Diaphragm impairment in methylprednisolone-treated emphysematous hamsters is in part reversed by anabolic steroids. Eur Resp J Suppl 10, 356S.
45. Wanner A, Horvath G, Brieva JL, Kumar SD & Mendes ES (2004). Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma. Proc Am Thorac Soc 1, 235-238.
46. Xu H, Wu XR, Wewer UM & Engvall E (1994). Murine muscular-dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat Genet 8, 297-302.